Literature DB >> 7828099

Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association.

R Jaeschke1, G Guyatt, H Shannon, S Walter, D Cook, N Heddle.   

Abstract

In the third of a series of four articles the authors show the calculation of measures of association and discuss their usefulness in clinical decision making. From the rates of death or other "events" in experimental and control groups in a clinical trial, we can calculate the relative risk (RR) of the event after the experimental treatment, expressed as a percentage of the risk without such treatment. The absolute risk reduction (ARR) is the difference in the risk of an event between the groups. The relative risk reduction is the percentage of the baseline risk (the risk of an event in the control patients) removed as a result of therapy. The odds ratio (OR), which is the measure of choice in case-control studies, gives the ratio of the odds of an event in the experimental group to those in the control group. The OR and the RR provide limited information in reporting the results of prospective trials because they do not reflect changes in the baseline risk. The ARR and the number needed to treat, which tells the clinician how many patients need to be treated to prevent one event, reflect both the baseline risk and the relative risk reduction. If the timing of events is important--to determine whether treatment extends life, for example--survival curves are used to show when events occur over time.

Entities:  

Mesh:

Year:  1995        PMID: 7828099      PMCID: PMC1337533     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  15 in total

1.  Should there be a moratorium on the use of cholesterol lowering drugs?

Authors:  G Davey Smith; J Pekkanen
Journal:  BMJ       Date:  1992-02-15

2.  A consumer's guide to subgroup analyses.

Authors:  A D Oxman; G H Guyatt
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

3.  Absolutely relative: how research results are summarized can affect treatment decisions.

Authors:  L Forrow; W C Taylor; R M Arnold
Journal:  Am J Med       Date:  1992-02       Impact factor: 4.965

4.  Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.

Authors:  G V Stiegmann; J S Goff; P A Michaletz-Onody; J Korula; D Lieberman; Z A Saeed; R M Reveille; J H Sun; S R Lowenstein
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

5.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

6.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1994-01-05       Impact factor: 56.272

7.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

8.  Completeness of reporting trial results: effect on physicians' willingness to prescribe.

Authors:  M Bobbio; B Demichelis; G Giustetto
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

9.  Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration.

Authors:  H C Bucher; M Weinbacher; K Gyr
Journal:  BMJ       Date:  1994-09-24

10.  Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

Authors:  C D Naylor; E Chen; B Strauss
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391

View more
  26 in total

Review 1.  The effects of information framing on the practices of physicians.

Authors:  P McGettigan; K Sly; D O'Connell; S Hill; D Henry
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

2.  A comparison of the statistical power of different methods for the analysis of repeated cross-sectional cluster randomization trials with binary outcomes.

Authors:  Peter C Austin
Journal:  Int J Biostat       Date:  2010-03-29       Impact factor: 0.968

3.  What is so odd about odds?

Authors:  Bernard Montreuil; Yves Bendavid; James Brophy
Journal:  Can J Surg       Date:  2005-10       Impact factor: 2.089

Review 4.  Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder.

Authors:  Zuowei Wang; David E Kemp; Philip K Chan; Yiru Fang; Stephen J Ganocy; Joseph R Calabrese; Keming Gao
Journal:  Int J Neuropsychopharmacol       Date:  2010-09-29       Impact factor: 5.176

Review 5.  Reasons or excuses for avoiding meta-analysis in forest plots.

Authors:  John P A Ioannidis; Nikolaos A Patsopoulos; Hannah R Rothstein
Journal:  BMJ       Date:  2008-06-21

6.  Statistics: a brief overview.

Authors:  Ryan Winters; Andrew Winters; Ronald G Amedee
Journal:  Ochsner J       Date:  2010

Review 7.  Interpreting treatment effects in randomised trials.

Authors:  G H Guyatt; E F Juniper; S D Walter; L E Griffith; R S Goldstein
Journal:  BMJ       Date:  1998-02-28

Review 8.  A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: a review.

Authors:  Peter C Austin; Andreas Laupacis
Journal:  Int J Biostat       Date:  2011-01-06       Impact factor: 0.968

9.  Illustrating risk difference and number needed to treat from a randomized controlled trial of spinal manipulation for cervicogenic headache.

Authors:  Mitchell Haas; Michael Schneider; Darcy Vavrek
Journal:  Chiropr Osteopat       Date:  2010-05-24

10.  Risk stratification for sudden cardiac death: current approaches and predictive value.

Authors:  Gustavo Lopera; Anne B Curtis
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.